ǰÑÔ
ÒÈÏÙÑ×(pancreatitis)·ÖΪ¼±ÐÔÒÈÏÙÑ׺ÍÂýÐÔÒÈÏÙÑס£¼±ÐÔÒÈÏÙÑײ¡ÇéÒõÏÕ¡¢éæÃüÂʸߣ¬¶øÂýÐÔÒÈÏÙÑ׳ÊÖØ¸´±¬·¢µÄ¸¹Í´£¬ÇÒºÍÒÈÏÙ°©¹ØÏµÇ×½ü£¬¹ÊÁ½Õß³ÉΪÁÙ´²ÆÈÇÐÐèÒª½â¾öµÄÎÊÌâ¡£×î½üÔÚÐí¶à¶¯ÎïÄ£×ÓÉÏ֤ʵ£¬¼±ÐÔÒÈÏÙÑ×(acute pancreatitis, AP)µÄ·¢²¡Ôµ¹ÊÔÓɼ°ÑÏÖØË®Æ½ºÍµ¨ÖËá´Ì¼¤¡¢ÑÏÖØ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢¡¢ÒÒ´¼ºÍÈÜѪÏà¹Ø£¬»úÖÆÉϱ£´æÏ¸°ûĤͨ͸ÐÔÔöÌí¡¢Ã¸ÔÒì³£¼¤»î¡¢Ñ×Ö¢·´Ó¦¡¢Ï¸°ûµòÍö¡¢ÄÚÖÊÍøÓ¦¼¤¡¢Ñõ»¯Ó¦¼¤¡¢ÓÎÀëÖ¬·¾Ëá¶¾ÐԵȶàÖÖ²¡Àí;¾¶¡£ÂýÐÔÒÈÏÙÑ×(chronic pancreatitis,CP)µÄÌØÕ÷ÊÇÒ»Á¬ºÍÖØ¸´µÄÑ×Ö¢·´Ó¦µ¼ÖÂÏËά»¯µÈ¾ÙÐÐÐԵIJ¡Àíת±ä£¬×îÖÕÄÚ¡¢ÍâÉøÍ¸×éÖ¯ÆÆËð¡£ÔÚ½üÆÚµÄ¶¯ÎïÄ£×ÓÑо¿ÉÏ£¬Ö¤ÊµÑ×Ö¢Òò×Óµ¼ÖÂÒÈÏÙÎÀÐÇϸ°ûµÄÔöÖ³ºÍÊÍ·Åϸ°ûÍâ»ùÖÊ£¬ÊÇÏËά»¯¼ÓÖØµÄÖ÷ÒªÔµ¹ÊÔÓÉ£¬¶øÉñ¾ÃâÒß·´Ó¦Ôò¼Ó¾çÁËÌÛÍ´·´Ó¦¡£ÒÒ´¼ÊÇÂýÐÔÒÈÏÙÑ××îÖ÷ÒªµÄ·¢²¡ÒòËØ£¬Ò²ÔÚһϵÁÐÄ£×ÓÉÏ»ñµÃÑéÖ¤¡£´ó×Úת»ùÒòºÍ»ùÒòÇóýСÊóÔÚ¼±ÐÔºÍÂýÐÔÒÈÏÙÑ×ʵÑéÑо¿ÖеÄÓ¦Óã¬Ê¹ÒÈÏÙÑ×µÄÒÅ´«Ïà¹ØÒòËØÒÔ¼°·Ö×Ó»úÖÆµÄÑо¿µÃÒÔ´ó×ڵؿªÕ¹£¬ÒÈÏÙÑ׺ÍÐí¶àµ¥»ùÒòµÄÏà¹ØÐÔÖð²½»ñµÃÃ÷È·¡£
ÏÖÔÚ£¬Ñо¿ÖÐÓ¦ÓÃ×î¹ãµÄÒÈÏÙÑ×¶¯ÎïÄ£×ÓÊÇÄö³ÝÀදÎÈç´óÊó¡¢Ð¡Êó£¬Ò²ÓеØÊ󣬯äËû¶¯ÎïÒ²Óб¨µÀ¡£×Ô¾õÐÔÒÈÏÙÑ׵͝ÎïÄ£×ÓÔÚÑо¿Öл¹Î´»ñµÃÏÖʵӦÓá£Æ¾Ö¤ÔìÄ£ÒªÁ죬ÓÕ·¢ÐÔÄ£×Ó¿É·ÖΪ·ÇÇÖÈë·¨£¨ÒûʳÓÕµ¼¡¢»¯Ñ§ÓÕµ¼µÈ£©ºÍÇÖÈë·¨£¨ÄæÐÐÐÔµ¨¹Ü×¢Éä¡¢ÒȹܽáÔú»òÛձյȣ©Á½´óÀàÄ£×Ó£¬Èçͼ7-3Ëùʾ¡£µ±½ñµÄÒÈÏÙÑ×Ñо¿Ç÷ÊÆÔ½À´Ô½ÇãÏòÓÚ¶àÖÖÒÈÏÙÑ×Ä£×ÓÓ¦ÓÃÓÚͳһ¸öÑо¿£¬ÒÔɨ³ýÄ£×ÓÌØÒìÐÔ»ò¶¯ÎïÖÖÀàÌØÒìÐÔ¶ÔʵÑéЧ¹ûµÄ×ÌÈÅ¡£
ͼ7-3 ÒÈÏÙÑ×Ä£×ÓÖÆ±¸Ê¾Òâͼ
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯ÎСÊó
ÓêÍÜËØÓÕ·¢ÒÈÏÙÑ×¶¯ÎïÄ£×Ó ÓêÍÜËØ(caerulein)Êǵ¨ÄÒËõ¶ÌËØ(cholecystokinin,CCK)µÄÀàËÆÎï¡£µ¨ÄÒËõ¶ÌË÷ÊÇÓÉ33¸ö°±»ùËá×é³ÉµÄ¶àëļ¤ËØ£¬Ö÷ÒªÐÄÀí×÷ÓÃÊǴ̼¤µ¨ÄÒËõ¶ÌÓë°ÂµÒÀ¨Ô¼¼¡ËÉи£»Ôö½ø¸Îµ¨ÖÉøÍ¸£»µ÷ÀíС³¦¡¢½á³¦Ô˶¯£»´Ì¼¤ÒÈÏÙÍâÉøÍ¸£»×÷ΪÄÔ³¦¼¤Ëص÷ÀíÉãʳ¡£
¡¾ÔìÄ£»úÖÆ¡¿£º
¹ýÁ¿¸øÓèÓêÍÜËØ£¬Í¨¹ýCCKÊÜÌ壬´Ì¼¤ÒÈÏÙÏÙÅÝϸ°ûÌ«¹ýÉøÍ¸£¬²¢Ê¹Ï¸°ûÄÚµÄÒÈÂѰ×øԺÍÈÜøÌåË®½âøÊèÉ¢Õϰ£¬¾×éÖ¯ÂѰ×øBÒÀÀµÐԵķ½·¨¼¤»î£¬ÒÈøµÄ»îÐÔÓÖÄܹ»½øÒ»²½µ¼ÖÂøԼ¤»î£¬ÒýÆðһϵÁÐÂѰ×ø»îÐÔµ¼ÖµÄϸ°ûË𺦡£ÒÈÏÙ×éÖ¯×ÔÎÒÏû»¯ÒýÆðµÄÑ×Ö¢·´Ó¦ÕÙļÑ×֢ϸ°û£¬ÊÍ·ÅÑ×Ö¢Òò×Ó£¬½øÒ»²½ÒýÆð¾Ö²¿ÉõÖÁÈ«ÉíÐÔµÄÑÏÖØÑ×Ö¢·´Ó¦¡£
¼±ÐÔÒÈÏÙÑ׵ķ¢²¡ÒòËØÒѾ½ÏÁ¿ÇåÎú£¬¿ÉÒÔÄ£ÄâÈËÀ༲²¡±¬·¢µÄ·½·¨ÔìÄ£¡£È»¶ø£¬ÂýÐÔÒÈÏÙÑ׵ķ¢²¡»úÖÆÖÁ½ñ»¹²»ÇåÎú£¬Ê¹Óü±ÐÔÒÈÏÙÑ×ÖØ¸´±¬·¢µ¼ÖÂÂýÐÔÒÈÏÙÑ×µÄÔÀí£¬¶à´ÎÖØ¸´ÓÕµ¼¼±ÐÔÒÈÏÙÑ×ʹÒÈÏÙÌåÏÖÏËά»¯µÈÂýÐÔÒÈÏÙÑײ¡ÀíÌØÕ÷£¬ÊÇÂýÐÔÒÈÏÙÑ×µÄÒ»¸ö»ù±¾ÔìÄ£»úÖÆ¡£
ÓêÍÜËØÓÕµ¼ÒÈÏÙÑ×ʱ£¬ÍùÍùÍŽáÓ¦ÓÃÔöÌíÒÈÏÙÑ×Ò׸ÐÐÔµÄÒòËØ£¬ÈçÄÚ¶¾ËØ¡¢ÒÒ´¼¡¢¸ß¸ÊÓÍÈýõ¥ÑªÖ¢µÈ¡£
Ö¬¶àÌÇ(lipopolysaccharides,LPS)ÊÇÒ»ÖÖÄÚ¶¾ËØ£¬Ëü¿ÉÒÔͨ¹ý¼¤»îµ¥ºËϸ°û½ø¶øÊÍ·Åϸ°ûÒò×Ó£¬ ÒýÆðÈ«ÉíÐÔÑ×Ö¢·´Ó¦¡£ÁÙ´²Ñо¿·¢Ã÷LPSˮƽÓë¼±ÐÔÒÈÏÙÑ×µÄÑÏÖØË®Æ½Ç×½üÏà¹Ø¡£ÓêÍÜËØÓëLPSÍŽáÓ¦ÓÃÔÚ½¨ÉèÒÈÏÙÑ×Ä£×ÓʱÓÐÐͬ×÷Óá£LPSÆÆËðÑ×Ö¢½éÖʵÄÕý³£·´Ó¦£¬½ø¶øÉú³¤¾Ö²¿µÄÒÈÏÙÑ×ΪȫÉíÐÔµÄÑÏÖØÐÔÑ×Ö¢·´Ó¦£¬¼ÓÖØÔÚÓêÍÜËØÓÕ·¢»ù´¡ÉϵÄÒÈÏÙÑס£
ÒÒ´¼¿ÉÒÔÔöÌíÒÈÏÙµÄÑõ»¯Ó¦¼¤¡¢ÆÆËðÏÙÅÝϸ°ûµÄÏßÁ£Ì塢ʹÒÈÂѰ×øÔÒ׻£¬Í¬Ê±¸Ä±äÉñ¾ÄÚÉøÍ¸µ÷Àí£¬Ê¹Ï¸°ûéæÃü´ÓµòÍöÏò»µËÀת»¯£¬Í¨¹ý¿¹Ñ×·´Ó¦Ôö½øÒÈÏÙÏËά»¯¡£Òò´Ë£¬ÆñÂÛ¼±ÐÔÒÈÏÙÑ×ÕÕ¾ÉÂýÐÔÒÈÏÙÑ×Ä£×ÓµÄÖÆ±¸£¬Í¨¹ýÒÒ´¼µÄÓ¦ÓÿÉÒÔÔö½øÆäËûÒªÁìÓÕµ¼µÄÒÈÏÙÑס£
¸ß¸ÊÓÍÈýõ¥ÑªÖ¢(hypertriglyceridemia)ÊǼ±ÐÔÒÈÏÙÑ×µÄÖ÷Òª·¢²¡Ôµ¹ÊÔÓÉ£¬¿ÉÊÇ»úÖÆÖÁ½ñ²»ÇåÎú¡£¶Ô¸ß¸ÊÓÍÈýõ¥ÑªÖ¢Ä£×ÓÓÃÓêÍÜËØ¾ÙÐÐÒÈÏÙÑ×ÓÕµ¼£¬ÒѾ±»Ö¤Êµ¿ÉÒÔ¼ÓÖØÒÈÏÙÑ×ÑÏÖØË®Æ½£¬¿ÉÊÇÖ»ÓÐÑÏÖØ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢(>100mg/dl)Ä£×ӲŻªÊӲ쵽£¬ÕâÀàÄ£×ÓºÜÉÙ¡£ÏÖÔÚ³ýÁËÖ¬ÂѰ×֬øºÍÆä¸¨ÖúÒò×ÓGPIHBP1ÇóýСÊ󣬼°ÆäÒÖÖÆ¼ÁApoC3ת»ùÒòСÊó¾ßÓÐÑÏÖØ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢±íÐÍ£¬Ö»ÓеØÊó¿ÉÒÔͨ¹ýιËÇÒªÁìÔì³ÉÑÏÖØ¸ß¸ÊÓÍÈýõ¥Ö¢¡£ÁíÍ⣬GPIHBP1Çóý´óÊó×î½üÖÆ±¸Àֳɣ¬¼øÓÚ´óÊóÔÚ¼±ÐÔÒÈÏÙÑ×Ñо¿ÖеÄÓÅÊÆ£¬ËüÓпÉÄܳÉΪδÀ´¼±ÐÔÒÈÏÙÑ×µÄ×î¼Ñ¹¤¾ß¡£ÕâЩģ×Ó¿ÉÒÔ×÷Ϊ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢ÐÔ¼±ÐÔÒÈÏÙÑ×µÄÑо¿¹¤¾ß¡£
¶þÂȶþ¶¡»ùÎý(dibutyltin dichloride,DBTC)µÈ¶þÍé»ùÎý¿Éµ¼Öµ¨¹ÜÉÏÆ¤Ï¸°ûÆÆËð£¬ÒýÆðË®Ö×ÔöÉú£¬ÒýÆðÒȵ¨¹Ü¹£Èû£¬Ðγɼ±ÐÔ¼äÖÊÐÔÒÈÏÙÑ×£¬ÂýÐÔÑ×Ö¢µ¼ÖÂÒÈÏÙÏËά»¯¡£DBTC¾³£±»ºÍÓêÍÜËØÍŽáÓ¦Óã¬Ôì³É½ÏÁ¿µä·¶µÄÂýÐÔÒÈÏÙÑ×Ä£×Ó¡£
¡¾ÔìÄ£ÒªÁì¡¿£º
ÀíÂÛÉϽ²£¬ÓêÍÜËØ¿ÉÒÔÓÕµ¼´ó´ó¶¼¶¯Îﱬ·¢¼±ÐÔÒÈÏÙÑ×£¬¿ÉÊÇ´ËÀàÄ£×ÓÖ÷ÒªÓ¦ÓÃÓÚÄö³ÝÀදÎÈç´óÊóºÍСÊ󣩡£´óÊó5~20µg/kgÌåÖØ£¬4¡«6СʱÄÚÿСʱһ´Î¸¹Ç»»òƤÏÂ×¢É䣻СÊó20-50µg/kgÌåÖØ£¬¸¹Ç»×¢Éä7´Î£¬Ã¿Ð¡Ê±Ò»´Î¡£ËäÈ»µØÊó²»Êdz£Óõļ±ÐÔÒÈÏÙÑ×Ä£×Ó£¬µ«ÓÉÓÚÆäÔÚÖ¬´úл·½ÃæµÄÍ»³öÓÅÊÆ£¬Ñо¿·¢Ã÷Æä¶ÔÓêÍÜËØÓÕµ¼µÄ¼±ÐÔÒÈÏÙÑ×ͬÑùÃô¸Ð£¬Æ¾Ö¤´óÊó»òСÊóµÄ·½·¨ÓÕµ¼¾ù¿É¡£
ÓêÍÜËØÓÕµ¼µÄÂýÐÔÒÈÏÙÑ×ÊǸÃÄ£×ÓÖÆ±¸µÄ»ù±¾ÒªÁì¡£ÆñÂÛÄÄÖÖ¶¯Î¶à´ÎÓÕµ¼¼±ÐÔÒÈÏÙÑ×£¬Ã¿ÖÜÒ»´ÎÒ»Á¬ÊýÖÜÃܸü³¤Ê±¼ä£¬½«·ºÆð½Ïµä·¶µÄÂýÐÔÒÈÏÙÑ׵IJ¡ÀíÌåÏÖ¡£Ð¡ÊóÕÕ¾ÉÂýÐÔÒÈÏÙÑ×Ä£×ÓÖÐ×î³£Óõ͝ÎÓÉÓÚ»ùÒòÐÞÊÎСÊóÊÇÂýÐÔÒÈÏÙÑ׺͵¥»ùÒò¹ØÏµµÄÖ÷ÒªÑо¿¹¤¾ß¡£
ʹÓÃLPSÍŽáÓêÍÜËØÓÕµ¼¼±ÐÔÒÈÏÙÑ×ʱ£¬Ò»Ñùƽ³£5~15mg/kg¸¹Ç»×¢ÉäÒ»´Î£¬ÔÚ×îºóÒ»´ÎÓêÍÜËØ×¢Éäʱ¼ÓÈë»òÖ®ºó×¢Éä¡£Óб¨µÀÓêÍÜËØÍŽáLPSʱ£¬¿ÉïÔÌÒ»´ÎÓêÍÜËØ×¢Éä¡£
ÒÒ´¼¼È¿ÉÒÔµ¥¶ÀÒ²¿ÉÒÔºÍÓêÍÜËØÍŽáÓ¦ÓÃÓÕµ¼¼±ÐÔºÍÂýÐÔÒÈÏÙÑס£ÒÒ´¼¿ÉÒÔͨ¹ý¹àθ¼±ÐÔ´ó×Ú¸øÓè¡£Èô¶ÔСÊó¾ÙÐÐʵÑ飬×î´ó×Ú¿ÉÒÔ¸øµ½50%~60%ÒÒ´¼100μl£¬Ò»Ìì4´Î£¬»ò20£¥ÒÒ´¼10´Î£¯d¡£ÔÚÒ°ÉúСÊóÉÏ£¬²»ÓÕ׿±ÐÔÒÈÏÙÑ×£¬Ò²²»¼ÓÖØÓêÍÜËØÓÕµ¼µÄ¼±ÐÔÒÈÏÙÑס£ºã¾ÃÂýÐÔ¸øÓèÒÒ´¼ÊÇÂýÐÔÒÈÏÙÑ×ÖÆ±¸³£ÓõÄÒªÁì¡£¸øÓèÒÒ´¼µÄ·½·¨×î¿É¿¿µÄÊÇLieber-DeCarliÒûʳÊÖÒÕ£¬Äܹ»°ü¹Ü¶¯Îïºã¾ÃÉãÈ¡×ãÁ¿ÒÒ´¼ÓëÓªÑø£¬²¢ÓÐÓÃɨ³ýÒòºã¾ÃÉãÈ¡ÒÒ´¼¶øÒýÆðµÄÓªÑøÕϰ£¬Lieber-Decarli¼´ÊÇ1963 ÄêÌá³öº¬È«ÓªÑøËغÍÒÒ´¼µÄÒºÌåʳÁÏ£¬°´ÈÈÁ¿ÅäÖÆÂѰ×ÖÊ18%¡¢Ö¬·¾21%¡¢Ì¼Ë®»¯ºÏÎï47%(36£¥ÈÈÁ¿ÓÉÒÒ´¼È¡´ú£©£¬ÉÐÓÐһЩάÉúËØºÍÎÞ»úÑεȡ£Í¨³£¸øÓè10ÖÜÒÒ´¼ºó£¬ÔÙÔöÌíLPS(3mg/kg)Ò»ÖÜÒ»´Î£¬Ò»Á¬3ÖÜ£¬ÓÕµ¼ÂýÐÔÒÈÏÙÑס£
ÓêÍÜËØÍŽáDBTCÖÆ±¸ÂýÐÔÒÈÏÙÑ×£¬´óÊóÓ¦Óý϶ࡣDBTCÈÜÔÚ100£¥ÒÒ´¼ÖУ¬ÔÙÓøÊÓÍÏ¡ÊÍ£¬°´4.5mg/kgÌåÖØµÄ¼ÁÁ¿Î²¾²Âö×¢ÉäÒ»´Î¡£Ò²ÓÐÓÃDBTCÍŽáÒÒ´¼ÖƱ¸ÂýÐÔÒÈÏÙÑ×Ä£×ӵġ£
¡¾Ä£×ÓÌØµã¡¿£º
×¢ÉäÓêÍÜËØºó¶¯ÎïѪ½¬µí·Ûø¡¢Ö¬·¾Ã¸µÄ·åÖµÉý¸ß£¬·ù¶È´Ó¼¸Ê®±¶µ½ÉÏǧ±¶¶¼Óб¨µÀ£¬¿ÉÄܺÍÓÃÒ©¼ÁÁ¿ºÍ²î±ðʵÑéÊҲⶨҪÁì²î±ðÓйء£ÒÈÏÙ×é֯ˮÖס¢Ñ×ÐÔϸ°û½þÈó£¬Í¬Ê±°éÓÐÉÙÊóÏÙϸ°û»µËÀ£¬ÓÐʱÓгöѪ£¬¾³£ÔÚ²¡ÀíÇÐÆ¬ÉÏ¿´µ½ÒÈÏÙ×éÖ¯ÓÐÔ²ÐεĿÕÅÝ¡£ÑªÇåºÍÒÈÏÙ×éÖ¯Ñ×Ö¢Òò×Ó±í´ïˮƽÔö¸ß¡£Ï¸°ûµòÍöºÍ×ÔÊÉÔÚÕâÀàÄ£×ÓµÄÒÈÏÙÑ׵IJ¡Àí»úÖÆÖУ¬²î±ðµÄ¶¯ÎïÖÖÀàÌåÏÖ²î±ð¡£ÓêÍÜËØÓÕµ¼ÒÈÏÙÑ׵͝ÎïÄ£×Ó»¹¿ÉÌåÏÖ³öµä·¶µÄ¼±ÐÔÒÈÏÙÑ×Ïà¹Ø·ÎËðÉË£¬ÌØÊâÊÇÍŽáÓ¦ÓÃLPS¡£
ÂýÐÔÒÈÏÙÑ×Ä£×ӵIJ¡ÀíÌØµã°üÀ¨£ºÍâÉøÍ¸ºÍÄÚÉøÍ¸Ï¸°ûµÄÅúµÄɥʧ£¬µä·¶µÄÂýÐÔÑ×Ö¢ÌØµã£¬µ¼¹ÜÄÚÂѰ×˨ºÍ¸Æ»¯Ðγɣ¬ÌÛÍ´Ãô¸Ð£¬ÒÔ¼°ÒÈÏÙÏËά»¯¡£
¡¾Ä£×ÓÆÀ¹ÀºÍÓ¦Óá¿£º
ÓÉÓÚÓêÍÜËØÓÕµ¼¼±ÐÔÒÈÏÙÑײÙ×÷ÇáÓ¯£¬ÊµÑéÖÜÆÚ¶Ì£¬Öظ´ÐԺ㬹ÊÒѳÉΪÒÈÏÙÑ×ÔìÄ£×î³£Óõķ½·¨¡£ÕâÀàÄ£×ÓÊÊÓÃÓÚÑо¿¼±ÐÔÒÈÏÙÑ×µÄϸ°ûÉúÎïѧ»úÖÆ£¬ÔÚ·¢²¡µÄÒÅ´«ºÍÇéÐÎÒòËØÑо¿ÖÐʩչÁËÖ÷Òª×÷Óá£ÏÖÔÚÒѾ±¨µÀµÄ¶¯ÎïÖÖÀàÓдóÊó¡¢Ð¡Êó¡¢¹·¡¢¼ÒÍú͵ØÊó¡£ÓêÍÜËØÓÉÓÚÀàËÆÎïCCK¿ÉÒÔÓ¦ÓÃÓÚÌåÍâʵÑéÑо¿£¬Ä£ÄâÓêÍÜËØµÄÌåÄÚʵÑé×÷ÓûúÖÆ£¬Òò´Ë¸üÓÐÀûÓÚϸ°ûÉúÎïѧÑо¿¡£ÓêÍÜËØÓÕµ¼ÇáÖжȼ±ÐÔÒÈÏÙÑ×£¬¿ÉÒÔ×ÔÓú£¬Òò´ËÓÃÓÚÔçÆÚϸ°û»úÖÆºÍÏÙÅÝϸ°ûËðÉËÐÞ¸´Ñо¿£¬ÓÐÀûÓÚÊÓ²ìеķÀÖÎÒªÁìµÄ×÷Ó᣿ÉÊÇ£¬ÔÚÆÀ¼Û·ÀÖÎÒªÁìʱ£¬µí·Ûø¡¢Ö¬·¾Ã¸²»ÊÇÃô¸ÐÖ¸±ê£¬Éú»¯Ö¸±ê·½ÃæÒªÒÀÀµÑ×Ö¢Òò×ӵIJⶨ£¬ÏÖÔÚ»¹Ã»Óкܺõı¾Ç®½ÏµÍ¡¢ÇáÓ¯¿ÉÐеÄÒªÁì¡£
¸ÃÄ£×ÓÐèҪעÉä´ó¼ÁÁ¿µÄÓêÍÜËØ£¬±¾Ç®²»µÍ£¬ÓÕµ¼¾ßÓÐ×ÔÏÞÐԵļ±ÐÔÒÈÏÙÑ×£¬Ð¡ÊóÏà¶Ô¸ü²»Ãô¸Ð¡£¶ø²î±ðƷϵµÄСÊó¶ÔÓêÍÜËØÓÕµ¼µÄÒÈÏÙÑ×µÄÃô¸ÐÐÔÏà½ÏÁ¿£¬BALB/c¡¢ICRСÊó½ÏÃô¸Ð£¬C57BL/6СÊóÃô¸ÐÐԽϲÓêÍÜËØÓÕµ¼µÄÒÈÏÙÑ×ÔÚͳһƷϵÖУ¬Ò²»áÓÐÒÈÏÙÑ×Àú³ÌµÄÉÙÐíµÄ²î±ð¡£Òò´Ë£¬ÕâÀàÄ£×ÓÓ¦ÓÃʱ£¬±ØÐèÓкÏÊʵıÈÕÕ×飬²¢¾ÙÐÐʱ¼äÒÀÀµÐÔÊӲ졣ÁíÍ⣬¸ÃÄ£×Ó²¢²»Ä£ÄâÈËÀà³£¼ûµÄ·¢²¡Ôµ¹ÊÔÓÉ£¬Ã»ÓÐéæÃüÖյ㣬ÆäËûµÄ½éÈëÐÔºÍÑÏÖØÐÔÒÈÏÙÑ×Ä£×Ó£¬ÔÚÑо¿Öо³£ÐèÒª×÷ΪÔö²¹ÐÔÄ£×Ó¡£ÔÚ×¢ÉäÓêÍÜËØµÄͬʱ¸øÓèLPS´Ì¼¤£¬Ò»¶¨Ë®Æ½ÉÏÌî²¹Á˼òµ¥Ê¹ÓÃÓêÍÜËØ½¨Ä£µÄ¾ÖÏÞ¡£
²Î¿¼ÎÄÏ×£º
1.±«ºì÷£¬³ÂÀò£¬Ñî·Æ£¬µÈ£®Ö¬ÂѰ×֬ø»ùÒòȱÏݵļ«¶Ë¸ß¸ÊÓÍÈýõ¥ÑªÖ¢Ð¡ÊóÒÈÏÙÑ×µÄÑо¿£®Öйú²¡ÀíÐÄÀíÔÓÖ¾£¬2006,22(7): 1277-1281
2.Archer H, Jura N, Keller J, et al. A mouse model of hereditary pancreatitis generated by transgenic expression of R122H lrypsinogen. GaslToenterology,2006,131 (6): 1844-1855
3.Bhandari M, Kawamoto M, Thomas AC, et al. Galanin receptor antagonist m35 but not m40 or c7 ameliorates cerulein-induced acute pancreatitis in mice. Pancreatology, 2010, 10(6):682-688
4.Chan YC, Leung PS. Acute pancreatitis: animal models and recent advances in basic research. Pancreas, 2007, 34 (1):1-14
5.Hu G, Zhao Y, Tang Y, et al. Development of a Novel Model of Hypertriglyceridemic Acute Pancrealitis in Hamsters Protective Effects of Probucol. Pancreas, 2012, 41 (6):845-848
6.Huber S,Ramsingh AI. Coxsackievirus-induced pancreatitis.Viral Immunol, 2004,.17 (3):358-369
7.Lombardi B, Rao NK. Acute hemorrhagic pancreatic necrosis in mice. lnfluence of the age and sex of the animals and of dietary ethionine, choline, methionine,and adenine sulfate. Am J Pathol, 1975, 81 (1):87-100
8.Marrache F, Tu SP, Bhagat G, et al. Overexpression of interleukin-lbeta in the murine pancreas results in chronic pancreatitis. Gastroenlerology,2008, 135(4): 1277-1287
9.Meagher C, Tang Q, Fife BT, el al. Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice. J lmn1unol, 2008, 180 (12):7793-7803
10.Moreno C,Nicaise C,Gustot T, et al. Chemokine receptor CCR5 deficiency exacerbates cerulein-induced acute pancreatitis in mice. Am J Physiol Gastrointesl Liver Physiol,2006,291 (6):G1089-1099
11.Wang Y, Sternfeld L, Yang F, et al. Enhanced susceptibility to pancreatitis in severe hypertriglyceridaemic lipoprotein lipase-deficient mice and agonist-like function of pancreatic lipase in pancreatic cells. Gut,2009, 58 (3): 422-430
12.Willemer S, Elsässer HP, Adler G. Hormone-induced pancreatitis. Eur Surg Res, 1992, 24 (Suppl 1): 29-39